Spring Intro 2023
16/02/2023
Common study designs and their application
The Organisation for Professionals in Regulatory Affairs
11
Important terminology
• “Blinding” means that the identity of study treatment remains unknown, even after randomisation • In a “double-blind” study, neither the investigator nor the patient knows which treatment group they have been assigned to
• “Bias” can be conscious or sub-conscious • It is essential to minimise the potential for bias that might affect the conclusions drawn from a clinical trial
The Organisation for Professionals in Regulatory Affairs
12
Made with FlippingBook Annual report maker